Epidemiology of Migraine in Men: Disease Presentation and Comorbidities from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study (S47.007)

Conclusions:Results suggest that there are sex differences in migraine disease presentation and comorbidities. Men had a lower attack frequency, less disability, and less allodynia than women. Men generally had fewer diagnosed comorbidities than women. Nevertheless, migraine can be disabling in men and the perception that migraine is a women’s disease may contribute to migraine stigma and present barriers to men’s treatment access.Study Supported by: Allergan plc, Dublin, IrelandDisclosure: Dr. Scher has received personal compensation for activities with Allergan, Inc. as an advisory board member. Dr. Wang has received personal compensation for activities with Allergan, GlaxoSmithKline, Pfizer, and Eli-Lilly. Dr. Katsarava has received personal compensation for activities with Allergan and Merck. Dr. Buse has received personal compensation for activities with Allergan and Lilly as an advisory board member. Dr. Fanning has received personal compensation for activities with Vedanta Research as an employee. Dr. Manack Adams has received personal compensation for activities with Allergan as an employee. Dr. Manack Adams holds stock and or stock options in Allergan as an employee. Dr. Lipton has received personal compensation from Allergan, American Headache Society, Autonomic Technologies, Boston Scientific, Bristol Myers Squibb, Cognimed, Colucid, Eli Lilly, eNeura Therapeutics, Merck, Novartis, Pfizer, TEVA, Vedanta.

Source: Neurology - April 17, 2017 Category: Neurology Authors: Scher, A., Wang, S.-J., Katsarava, Z., Buse, D., Fanning, K., Adams, A. M., Lipton, R. Tags: Headache: Basic and Clinical Science Source Type: research